跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
tungsten salts
首页
药物
tungsten salts
tungsten salts
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
TUNGSTEN (VI) SALTS FOR STIMULATING FERTILITY AND REPRODUCTION AND FOR IMPROVING THE EFFECTIVENESS OF ASSISTED REPRODUCTION TECHNIQUES
EP 3173382 B1
申请人: OXOLIFE SL
优先权: 2014
CN
EP
US
WO
5 件公开
PROCESS FOR THE PREPARATION OF TUNGSTEN (VI) SALT HYDRATES
EP 4368577 A1
申请人: OXOLIFE SL
优先权: 2022
CN
EP
US
WO
5 件公开
Method for manufacturing an epoxy compound and method for epoxidizing a carboncarbon double bond
US 8742145 B2
申请人: TAKUMI KIYOSHI
优先权: 2009
CN
US
3 件公开
ORAL COMPOSITION COMPRISING CHALK
EP 1284713 B1
申请人: UNILEVER NV
优先权: 2000
EP
US
2 件公开
Method for producing epoxy compound
US 11485717 B2
申请人: ENEOS CORP
优先权: 2018
CN
US
2 件公开
A VETERINARY COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF PROTOZOAN DISEASES IN ANIMALS, COMPRISING AN ESSENTIAL OIL AND METHOD OF PREPARATION THEREOF
EP 4178561 A1
申请人: ADIFEED SP Z O O
优先权: 2020
EP
WO
2 件公开
Process for producing epoxide compound
US 7074947 B2
申请人: SUMITOMO CHEMICAL CO
优先权: 2002
US
2 件公开
Tungstenic compound nutriment for preventing and treating calculus and gout class diseases of urinary system
CN 101744835 A
申请人: XIAOPING LIN
优先权: 2009
CN
Use of tungsten (VI) salts for the treatment of female infertility in non-diabetic mammals
US 9675638 B2
申请人: OXOLIFE SL
优先权: 2013
US
TUNGSTEN (VI) SALTS FOR USE FOR INCREASING ONGOING PREGNANCIES, FOR INCREASING LIVE BIRTH RATES AND/OR FOR INCREASING THE BIOCHEMICAL PREGNANCY RATE IN INFERTILE WOMEN
WO 2026008874 A1
申请人: OXOLIFE SL
优先权: 2024
WO
药物
反馈